ArticleScientific reports2025
Evolutionary analysis through structural modeling of FAM222 proteins reveals a novel disordered conserved domain in vertebrates that interacts with NLK.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Molecular characterization of FAM222B as a novel disease gene for dominant cardiovascular laterality defects.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Intrinsically disordered regions (IDRs) play essential roles in signaling by mediating protein-protein interactions that are both dynamic and specific. Many IDRs have evolved as kinase-binding modules, particularly in mitogen-activated protein kinase (MAPK) networks, where they facilitate critical regulatory interactions for signaling specificity. However, the evolutionary constraints that shape IDRs and their role in MAPK regulation remain poorly understood. Here, we identify DCD222, a highly conserved IDR within the FAM222 protein family, which interacts with Nemo-like kinase (NLK), an atypical MAPK involved in WNT, NOTCH, VEGF, mTOR, and TGF-β signaling. Phylogenetic analysis reveals that DCD222 has been conserved from cyclostomes to humans, indicating strong evolutionary constraints on its function. Using AlphaFold3, we show that DCD222 binds to NLK through an extended mechanism, in which a reverse docking (revD) motif engages the NLK docking groove in the C-lobe, and β-hairpin-like and β-sheet motifs insert into the N-lobe. We performed three independent atomistic simulations of the protein-protein complex to assess the stability of the interface and found that it remained stable throughout the runs. The interaction does not obstruct the kinase's catalytic site, suggesting that FAM222A and FAM222B are potential modulators of NLK rather than simple substrates. Our findings establish DCD222 as an evolutionarily constrained IDR, providing new insights into how disordered domains contribute to signaling adaptation in vertebrates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.